Clinical Trial Update: Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids

View source ↗

Summary

A clinical trial is evaluating low-dose corticosteroids to manage hepatitis caused by immune checkpoint inhibitors in cancer patients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Viral Hepatitis

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Immune Related Adverse Events, Immune-Mediated Hepatitis | Status: RECRUITING